Abstract
Venoms from Bothrops jararcussu Bothrops asper Bothrops atrox Bothrops pirajai Bothrops moojeni Bothrops alternatus and Bothrops (Bothriopasis) bilineata were fractionated using a simplified procedure based on-exchange chromatography on CM-Sepharose at pH 8.0 or reverse phase HPLC.The resulting elution profilesshowed important differences in the myotoxin contentof these venoms.The venoms froms B.alternatus,B.atrox and Bothriopsis bilineata did not contain the major myotoxin found in the other venoms.The amino acid sequences of the first 50 residues of the N-terminal region of the PLA2-Like mytoxins showed a homology of 90-96percent with other bothropic myotoxins.All of the myotoxins isolated induced rat paw edema, increased the level of plasma ceratine kinase and produced myonecrosis together with polymorphoniclear cell infiltration.
Keywords: Myotoxic Phospholipase A2, Bothrops Venom, Bothrops jararcussu, Bothrops asper, Bothrops atrox, Bothrops pirajai, Bothrops moojeni, Bothrops alternatus, Bothrops Bothriopsis, blineata
Protein & Peptide Letters
Title: Comparative Biochemical Studies of Myotoxic Phospholipase A2 From Bothrops Venom
Volume: 8 Issue: 3
Author(s): M. H. Toyama, A. M. Soares, S. H. Andriao-Escarso, J. C. Novello, B. Oliveira, J. R. Giglio, M. R.M. Fontes and S. Marangoni
Affiliation:
Keywords: Myotoxic Phospholipase A2, Bothrops Venom, Bothrops jararcussu, Bothrops asper, Bothrops atrox, Bothrops pirajai, Bothrops moojeni, Bothrops alternatus, Bothrops Bothriopsis, blineata
Abstract: Venoms from Bothrops jararcussu Bothrops asper Bothrops atrox Bothrops pirajai Bothrops moojeni Bothrops alternatus and Bothrops (Bothriopasis) bilineata were fractionated using a simplified procedure based on-exchange chromatography on CM-Sepharose at pH 8.0 or reverse phase HPLC.The resulting elution profilesshowed important differences in the myotoxin contentof these venoms.The venoms froms B.alternatus,B.atrox and Bothriopsis bilineata did not contain the major myotoxin found in the other venoms.The amino acid sequences of the first 50 residues of the N-terminal region of the PLA2-Like mytoxins showed a homology of 90-96percent with other bothropic myotoxins.All of the myotoxins isolated induced rat paw edema, increased the level of plasma ceratine kinase and produced myonecrosis together with polymorphoniclear cell infiltration.
Export Options
About this article
Cite this article as:
Toyama H. M., Soares M. A., Andriao-Escarso H. S., Novello C. J., Oliveira B., Giglio R. J., Fontes R.M. M. and Marangoni S., Comparative Biochemical Studies of Myotoxic Phospholipase A2 From Bothrops Venom, Protein & Peptide Letters 2001; 8 (3) . https://dx.doi.org/10.2174/0929866013409445
DOI https://dx.doi.org/10.2174/0929866013409445 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Facing Up the ROS Labyrinth - Where To Go?
Current Vascular Pharmacology Amiodarone - A ‘Broad Spectrum’ Antiarrhythmic Drug
Cardiovascular & Hematological Disorders-Drug Targets Structural Development, Haematological Immunological and Pharmacological Effects of Quinolones
Recent Patents on Anti-Infective Drug Discovery Current and Future Prospective of a Versatile Moiety: Imidazole
Current Drug Targets Editorial:Polypharmacology of Natural Products
Mini-Reviews in Organic Chemistry TiO2-Nanowired Delivery of Mesenchymal Stem Cells Thwarts Diabetes- Induced Exacerbation of Brain Pathology in Heat Stroke: An Experimental Study in the Rat Using Morphological and Biochemical Approaches
CNS & Neurological Disorders - Drug Targets Neonatal Ultrasound in Transport
Current Pediatric Reviews Characteristics Other than the Diagnostic Criteria Associated with Metabolic Syndrome: An Overview
Current Vascular Pharmacology Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies The Cancer Related Thrombotic Tendency in Sepsis
Current Drug Targets Bioactive Proteins and Peptides from Food Sources. Applications of Bioprocesses used in Isolation and Recovery
Current Pharmaceutical Design Evaluation of Two Recombinant Plasminogen Activators in Massive Pulmonary Embolism Model and Potato Carboxypeptidase Inhibitor (PCI) role in Inhibition of Thrombin Activatable Fibrinolysis Inhibitor TAFIa in Lungs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Design, Development and Optimization of Ramipril Solid Lipid Nanoparticles Using Solvent Emulsification and Evaporation Method
Nanoscience & Nanotechnology-Asia Mesoionic Oxatriazoles (MOTA): NO-Donating Characteristics and Pharmacology
Current Pharmaceutical Design N-Acetylcysteine and Other Preventive Measures for Contrast-Induced Nephropathy in the Intensive Care Unit
Current Medicinal Chemistry Under-Dosing of Etomidate for Rapid Sequence Intubation in the Emergency Department
Current Drug Safety Long Acting Betaxolol Ocular Inserts based on Polymer Composite
Current Drug Delivery Multicenter Randomized Controlled Trial for the Treatment of Ulcerative Colitis with a Leukocytapheresis Column
Current Pharmaceutical Design Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia
Current Pharmaceutical Design Kinins and Cardiovascular Diseases
Current Pharmaceutical Design